J&J Invests In Stent Manufacturing Capacity; Sales Driven By Cordis

Johnson & Johnson/Cordis plans to upgrade the coating process for its Cypher sirolimus-eluting stent so that it can satisfy more than half of the U.S. drug-eluting stent demand